Search
Creating a wet AMD drug using flower compounds
Latest news, posted 20 June 2022
Scientists working to unleash the power of the well-renowned hyacinth plant have revealed more about their work to beat macular disease.
‘I won’t let my eye condition stop me’
Latest news, posted 28 June 2022
A 30-year-old postie, recently diagnosed with retinal vein occlusion (RVO) will be taking on the Great North Run for the second consecutive year, to focus on things he can still do after losing his sight in one eye.
Could zebrafish speed up macular research?
Latest news, posted 30 June 2022
Scientists at the University of Sussex are looking into whether cells from the zebrafish eye can be manipulated to create a macula, which could be used in future research.
Partnership calls to combat eye treatment delays
Latest news, posted 1 July 2022
The Macular Society is working closely with health bodies across Wales in order to help them combat delays to eye care treatment in the country.
‘I was downhearted but Skills for Seeing lifted me’
Latest news, posted 1 July 2022
A volunteer trainer has shared his experience of the Skills for Seeing service, which offers one-to-one advice to help people make the best use of their remaining vision.
Gene editing to treat inherited macular disease
Latest news, posted 5 July 2022
A research team is making strides in using gene-editing techniques to treat a rare, inherited form of macular disease.
Eat for your eyes - how food is important for our sight
Latest news, posted 6 July 2022
What are the best foods to eat to look after your eyes?
Double donations for Amazon Prime Day
Latest news, posted 7 July 2022
The Macular Society will benefit from double donations on eligible purchases made by Amazon Prime members later this month, helping us to raise vital funds for macular research.
Cheaper drugs for wet AMD becoming available on the NHS
Latest news, posted 19 July 2022
New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.
New treatment option approved for patients with diabetic macular oedema
Latest news, posted 28 July 2022
Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).